Condition: Graft-Versus-Host Disease · Hematopoietic Stem Cell Transplantation · Child, Only · Sponsor: Sijia Gu
This is a single-center prospective, non-randomized controlled clinical study in China using CliniMACS TCRα/β+ cell depleted stem cell haploidentical donors versus conventional Beijing protocol for haploidentical hematopoietic stem cell transplantation in children.
This description comes directly from the study's public registry record.
Jing Chen, PhD · 38626161 · chenjing@scmc.com.cn
Always discuss trial participation with your own doctor first.
| Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06423131